Which peptides are FDA-approved?

Short answer

58 of the 116 profiles here are FDA-approved, according to the U.S. labels and FDA records their profiles cite. Seven more had an FDA approval that was later withdrawn or whose products are all discontinued; they are listed separately.

Each entry below quotes its profile and links to the full answer there.

Metabolic and weight 13

Heart and blood vessels 3

Liver 1

Hormones 9

Bone and growth 5

Gut and digestion 4

Brain, nerves and sleep 3

Skin 2

Sexual and reproductive health 3

Inflammation and immune 2

Cancer 8

Muscle 2

Infections 2

Other areas 1

PeptideScanner reports what the cited sources say. It is not medical advice and does not recommend using, buying or dosing any substance. Read the full disclaimer.

Citations

Sources

Coverage and sources →

Numbered markers in the text point here. Each link opens the original public record.

  1. 1
    TRULICITY (dulaglutide) injection, solution · SPL version 62 · published 2026-08-10 ↗

    DailyMed · U.S. National Library of Medicine · Official source · Source checked September 15, 2026

  2. 2
    Drugs@FDA application BLA125469 · original submission status AP · 2014-09-18 · dataset 2026-08-13 ↗

    Drugs@FDA via openFDA · Official source · Source checked August 14, 2026

  3. 3
    Exenatide injection · SPL version 17 · published 2026-06-30 ↗

    DailyMed · U.S. National Library of Medicine · Official source · Source checked July 22, 2026

  4. 4
    Drugs@FDA application NDA021773 · original submission status AP · 2005-04-28 · dataset 2026-08-13 ↗

    Drugs@FDA via openFDA · Official source · Source checked August 14, 2026

  5. 5
    Drugs@FDA application NDA022200 · original submission status AP · 2012-01-27 · dataset 2026-08-13 ↗

    Drugs@FDA via openFDA · Official source · Source checked August 14, 2026

  6. 6
    Drugs@FDA application NDA209210 · original submission status AP · 2017-10-20 · dataset 2026-08-13 ↗

    Drugs@FDA via openFDA · Official source · Source checked August 14, 2026

  7. 7
    Drugs@FDA application ANDA206697 · original submission status AP · 2024-11-19 · dataset 2026-08-13 ↗

    Drugs@FDA via openFDA · Official source · Source checked August 14, 2026

  8. 8
    GVOKE VIALDX (glucagon) injection, solution · SPL version 2 · published 2026-07-09 ↗

    DailyMed · U.S. National Library of Medicine · Official source · Source checked July 22, 2026

  9. 9
    Drugs@FDA application NDA012122 · original submission status AP · 1960-11-14 · dataset 2026-08-13 ↗

    Drugs@FDA via openFDA · Official source · Source checked August 14, 2026

  10. 10
    Drugs@FDA application NDA210134 · original submission status AP · 2019-07-24 · dataset 2026-08-13 ↗

    Drugs@FDA via openFDA · Official source · Source checked August 14, 2026

  11. 11
    Drugs@FDA application NDA212097 · original submission status AP · 2019-09-10 · dataset 2026-08-13 ↗

    Drugs@FDA via openFDA · Official source · Source checked August 14, 2026

  12. 12
    LANGLARA (insulin glargine-aldy) injection, solution · SPL version 5 · published 2026-07-08 ↗

    DailyMed · U.S. National Library of Medicine · Official source · Source checked July 22, 2026

  13. 13
    Drugs@FDA application BLA761412 · original submission status AP · 2026-04-29 · dataset 2026-08-13 ↗

    Drugs@FDA via openFDA · Official source · Source checked August 14, 2026

  14. 14
    Langlara (insulin glargine-aldy): BLA 761412 approval letter, April 29, 2026 ↗

    U.S. Food and Drug Administration · Official source · Source checked November 14, 2026

  15. 15
    Liraglutide injection, solution · SPL version 6 · published 2026-07-14 ↗

    DailyMed · U.S. National Library of Medicine · Official source · Source checked July 22, 2026

  16. 16
    Drugs@FDA application NDA022341 · original submission status AP · 2010-01-25 · dataset 2026-08-13 ↗

    Drugs@FDA via openFDA · Official source · Source checked August 14, 2026

  17. 17
    Drugs@FDA application NDA206321 · original submission status AP · 2014-12-23 · dataset 2026-08-13 ↗

    Drugs@FDA via openFDA · Official source · Source checked August 14, 2026

  18. 18
    Drugs@FDA application ANDA215503 · original submission status AP · 2024-12-23 · dataset 2026-08-13 ↗

    Drugs@FDA via openFDA · Official source · Source checked August 14, 2026

  19. 19
    Drugs@FDA application BLA208471 · original submission status AP · 2016-07-27 · dataset 2026-08-13 ↗

    Drugs@FDA via openFDA · Official source · Source checked August 14, 2026

  20. 20
    ADLYXIN, revised November 2024: U.S. prescribing information ↗

    U.S. Food and Drug Administration · Official source · Source checked September 15, 2026

  21. 21
    SOLIQUA 100/33 (insulin glargine and lixisenatide) injection · SPL version 25 · published 2026-03-20 ↗

    DailyMed · U.S. National Library of Medicine · Official source · Source checked July 22, 2026

  22. 22
    Drugs@FDA: MYALEPT (metreleptin), application 125390 · original approval February 24, 2014 ↗

    U.S. Food and Drug Administration · Official source · Source checked November 16, 2026

  23. 23
    MYALEPT (metreleptin) for injection · SPL version 18 · published 2025-03-10 ↗

    DailyMed · U.S. National Library of Medicine · Official source · Source checked November 16, 2026

  24. 24
    Drugs@FDA: FOUNDAYO (orforglipron calcium), NDA 220934 · original approval April 1, 2026 ↗

    U.S. Food and Drug Administration · Official source · Source checked November 16, 2026

  25. 25
    FOUNDAYO (orforglipron) tablet, film coated · SPL version 10 · published 2026-08-13 ↗

    DailyMed · U.S. National Library of Medicine · Official source · Source checked November 16, 2026

  26. 26
    SYMLINPEN (pramlintide acetate) injection · SPL version 18 · published 2024-08-20 ↗

    DailyMed · U.S. National Library of Medicine · Official source · Source checked July 22, 2026

  27. 27
    Drugs@FDA application NDA021332 · original submission status AP · 2005-03-16 · dataset 2026-08-13 ↗

    Drugs@FDA via openFDA · Official source · Source checked August 14, 2026

  28. 28
    WEGOVY (semaglutide) injection and tablet · SPL version 19 · published 2026-06-30 ↗

    DailyMed · U.S. National Library of Medicine · Official source · Source checked July 22, 2026

  29. 29
    Drugs@FDA application NDA209637 · original submission status AP · 2017-12-05 · dataset 2026-08-13 ↗

    Drugs@FDA via openFDA · Official source · Source checked August 14, 2026

  30. 30
    Drugs@FDA application NDA213051 · original submission status AP · 2019-09-20 · dataset 2026-08-13 ↗

    Drugs@FDA via openFDA · Official source · Source checked August 14, 2026

  31. 31
    Drugs@FDA application NDA215256 · original submission status AP · 2021-06-04 · dataset 2026-08-13 ↗

    Drugs@FDA via openFDA · Official source · Source checked August 14, 2026

  32. 32
    IMCIVREE (setmelanotide) solution · SPL version 14 · published 2026-04-02 ↗

    DailyMed · U.S. National Library of Medicine · Official source · Source checked July 22, 2026

  33. 33
    Drugs@FDA application NDA213793 · original submission status AP · 2020-11-25 · dataset 2026-08-13 ↗

    Drugs@FDA via openFDA · Official source · Source checked August 14, 2026

  34. 34
    EGRIFTA SV (tesamorelin) kit · SPL version 9 · published 2026-07-31 ↗

    DailyMed · U.S. National Library of Medicine · Official source · Source checked September 15, 2026

  35. 35
    Drugs@FDA application BLA022505 · original submission status AP · 2010-11-10 · dataset 2026-08-13 ↗

    Drugs@FDA via openFDA · Official source · Source checked August 14, 2026

  36. 36
    ZEPBOUND (tirzepatide) injection · SPL version 40 · published 2026-09-02 ↗

    DailyMed · U.S. National Library of Medicine · Official source · Source checked September 15, 2026

  37. 37
    Drugs@FDA application NDA215866 · original submission status AP · 2022-05-13 · dataset 2026-08-13 ↗

    Drugs@FDA via openFDA · Official source · Source checked August 14, 2026

  38. 38
    Drugs@FDA application NDA217806 · original submission status AP · 2023-11-08 · dataset 2026-08-13 ↗

    Drugs@FDA via openFDA · Official source · Source checked August 14, 2026

  39. 39
    Bivalirudin for injection, powder, lyophilized, for solution (Sandoz Inc.) · SPL version 5 · published 2026-07-29 ↗

    DailyMed · U.S. National Library of Medicine · Official source · Source checked November 15, 2026

  40. 40
    Drugs@FDA: ANGIOMAX (bivalirudin), NDA 020873 · original approval December 15, 2000 ↗

    U.S. Food and Drug Administration · Official source · Source checked November 15, 2026

  41. 41
    Eptifibatide injection (Baxter Healthcare Company) · SPL version 13 · published 2026-05-21 ↗

    DailyMed · U.S. National Library of Medicine · Official source · Source checked November 15, 2026

  42. 42
    Drugs@FDA: INTEGRILIN (eptifibatide), NDA 020718 · original approval May 18, 1998 ↗

    U.S. Food and Drug Administration · Official source · Source checked November 15, 2026

  43. 43
    VASOSTRICT (vasopressin) injection · SPL version 49 · published 2026-05-18 ↗

    DailyMed · U.S. National Library of Medicine · Official source · Source checked November 15, 2026

  44. 44
    Drugs@FDA: VASOSTRICT (vasopressin), NDA 204485 · original approval April 17, 2014 ↗

    U.S. Food and Drug Administration · Official source · Source checked November 15, 2026

  45. 45
    TERLIVAZ (terlipressin) for injection · SPL version 8 · published 2026-10-26 ↗

    DailyMed · U.S. National Library of Medicine · Official source · Source checked November 15, 2026

  46. 46
    Drugs@FDA: TERLIVAZ (terlipressin acetate), NDA 022231 · original approval September 14, 2022 ↗

    U.S. Food and Drug Administration · Official source · Source checked November 15, 2026

  47. 47
    DDAVP (desmopressin acetate) tablet · SPL version 7 · published 2025-12-10 ↗

    DailyMed · U.S. National Library of Medicine · Official source · Source checked November 15, 2026

  48. 48
    Drugs@FDA: DDAVP (desmopressin acetate), NDA 019955 · original approval September 6, 1995 ↗

    U.S. Food and Drug Administration · Official source · Source checked November 15, 2026

  49. 49
    PARSABIV (etelcalcetide) injection, solution · SPL version 15 · published 2026-03-16 ↗

    DailyMed · U.S. National Library of Medicine · Official source · Source checked November 15, 2026

  50. 50
    Drugs@FDA: PARSABIV (etelcalcetide), NDA 208325 · original approval February 7, 2017 ↗

    U.S. Food and Drug Administration · Official source · Source checked November 15, 2026

  51. 51
    SUPPRELIN LA (histrelin acetate) implant · SPL version 38 · published 2025-09-29 ↗

    DailyMed · U.S. National Library of Medicine · Official source · Source checked November 15, 2026

  52. 52
    Drugs@FDA: SUPPRELIN LA (histrelin acetate), NDA 022058 · original approval May 3, 2007 ↗

    U.S. Food and Drug Administration · Official source · Source checked November 15, 2026

  53. 53
    Lanreotide acetate injection · SPL version 3 · published 2025-06-02 ↗

    DailyMed · U.S. National Library of Medicine · Official source · Source checked July 22, 2026

  54. 54
    Drugs@FDA application NDA022074 · original submission status AP · 2007-08-30 · dataset 2026-08-13 ↗

    Drugs@FDA via openFDA · Official source · Source checked August 14, 2026

  55. 55
    Drugs@FDA application NDA215395 · original submission status AP · 2021-12-17 · dataset 2026-08-13 ↗

    Drugs@FDA via openFDA · Official source · Source checked August 14, 2026

  56. 56
    Drugs@FDA application ANDA217193 · original submission status AP · 2024-05-21 · dataset 2026-08-13 ↗

    Drugs@FDA via openFDA · Official source · Source checked August 14, 2026

  57. 57
    SYNAREL (nafarelin acetate) nasal solution · SPL version 23 · published 2026-03-10 ↗

    DailyMed · U.S. National Library of Medicine · Official source · Source checked November 15, 2026

  58. 58
    Drugs@FDA: SYNAREL (nafarelin acetate), NDA 019886 · original approval February 13, 1990 ↗

    U.S. Food and Drug Administration · Official source · Source checked November 15, 2026

  59. 59
    Octreotide acetate injection, solution · SPL version 2 · published 2026-02-02 ↗

    DailyMed · U.S. National Library of Medicine · Official source · Source checked July 22, 2026

  60. 60
    Drugs@FDA application NDA019667 · original submission status AP · 1988-10-21 · dataset 2026-08-13 ↗

    Drugs@FDA via openFDA · Official source · Source checked August 14, 2026

  61. 61
    Drugs@FDA application NDA021008 · original submission status AP · 1998-11-25 · dataset 2026-08-13 ↗

    Drugs@FDA via openFDA · Official source · Source checked August 14, 2026

  62. 62
    Drugs@FDA application NDA208232 · original submission status AP · 2020-06-26 · dataset 2026-08-13 ↗

    Drugs@FDA via openFDA · Official source · Source checked August 14, 2026

  63. 63
    Drugs@FDA application NDA213224 · original submission status AP · 2024-09-27 · dataset 2026-08-13 ↗

    Drugs@FDA via openFDA · Official source · Source checked August 14, 2026

  64. 64
    PITOCIN (oxytocin) injection · SPL version 15 · published 2026-05-21 ↗

    DailyMed · U.S. National Library of Medicine · Official source · Source checked November 15, 2026

  65. 65
    Drugs@FDA: PITOCIN (oxytocin), NDA 018261 · original approval November 19, 1980 ↗

    U.S. Food and Drug Administration · Official source · Source checked November 15, 2026

  66. 66
    YORVIPATH (palopegteriparatide) injection, solution · SPL version 10 · published 2026-11-09 ↗

    DailyMed · U.S. National Library of Medicine · Official source · Source checked November 15, 2026

  67. 67
    Drugs@FDA: YORVIPATH (palopegteriparatide), NDA 216490 · original approval August 9, 2024 ↗

    U.S. Food and Drug Administration · Official source · Source checked November 15, 2026

  68. 68
    SIGNIFOR (pasireotide) injection · SPL version 20 · published 2026-02-18 ↗

    DailyMed · U.S. National Library of Medicine · Official source · Source checked November 15, 2026

  69. 69
    Drugs@FDA: SIGNIFOR (pasireotide diaspartate), NDA 200677 · original approval December 14, 2012 ↗

    U.S. Food and Drug Administration · Official source · Source checked November 15, 2026

  70. 70
    TYMLOS (abaloparatide) injection, solution · SPL version 19 · published 2026-08-17 ↗

    DailyMed · U.S. National Library of Medicine · Official source · Source checked September 15, 2026

  71. 71
    Drugs@FDA application NDA208743 · original submission status AP · 2017-04-28 · dataset 2026-08-13 ↗

    Drugs@FDA via openFDA · Official source · Source checked August 14, 2026

  72. 72
    MIACALCIN (calcitonin salmon) injection, solution · SPL version 9 · published 2026-06-19 ↗

    DailyMed · U.S. National Library of Medicine · Official source · Source checked November 15, 2026

  73. 73
    Drugs@FDA: MIACALCIN (calcitonin salmon), NDA 017808 · original approval July 3, 1986 ↗

    U.S. Food and Drug Administration · Official source · Source checked November 15, 2026

  74. 74
    Drugs@FDA: INCRELEX (mecasermin [rDNA origin]), application 021839 · original approval August 30, 2005 ↗

    U.S. Food and Drug Administration · Official source · Source checked November 16, 2026

  75. 75
    INCRELEX (mecasermin) injection · SPL version 4 · published 2025-11-17 ↗

    DailyMed · U.S. National Library of Medicine · Official source · Source checked November 16, 2026

  76. 76
    Teriparatide injection, solution · SPL version 10 · published 2026-09-21 ↗

    DailyMed · U.S. National Library of Medicine · Official source · Source checked November 15, 2026

  77. 77
    Drugs@FDA application NDA021318 · original submission status AP · 2002-11-26 · dataset 2026-08-13 ↗

    Drugs@FDA via openFDA · Official source · Source checked August 14, 2026

  78. 78
    Drugs@FDA application NDA211939 · original submission status AP · 2019-10-04 · dataset 2026-08-13 ↗

    Drugs@FDA via openFDA · Official source · Source checked August 14, 2026

  79. 79
    Drugs@FDA application ANDA211097 · original submission status AP · 2023-11-16 · dataset 2026-08-13 ↗

    Drugs@FDA via openFDA · Official source · Source checked August 14, 2026

  80. 80
    Drugs@FDA application NDA218771 · original submission status AP · 2024-06-04 · dataset 2026-08-13 ↗

    Drugs@FDA via openFDA · Official source · Source checked August 14, 2026

  81. 81
    Drugs@FDA application ANDA214412 · original submission status AP · 2026-10-23 · dataset 2026-11-13 ↗

    Drugs@FDA via openFDA · Official source · Source checked November 15, 2026

  82. 82
    VOXZOGO (vosoritide) kit · SPL version 16 · published 2025-11-26 ↗

    DailyMed · U.S. National Library of Medicine · Official source · Source checked July 22, 2026

  83. 83
    Drugs@FDA application NDA214938 · original submission status AP · 2021-11-19 · dataset 2026-08-13 ↗

    Drugs@FDA via openFDA · Official source · Source checked August 14, 2026

  84. 84
    LINZESS (linaclotide) capsule · SPL version 39 · published 2026-06-01 ↗

    DailyMed · U.S. National Library of Medicine · Official source · Source checked July 22, 2026

  85. 85
    Drugs@FDA application NDA202811 · original submission status AP · 2012-08-30 · dataset 2026-08-13 ↗

    Drugs@FDA via openFDA · Official source · Source checked August 14, 2026

  86. 86
    TRULANCE (plecanatide) tablet · SPL version 15 · published 2024-04-05 ↗

    DailyMed · U.S. National Library of Medicine · Official source · Source checked July 22, 2026

  87. 87
    Drugs@FDA application NDA208745 · original submission status AP · 2017-01-19 · dataset 2026-08-13 ↗

    Drugs@FDA via openFDA · Official source · Source checked August 14, 2026

  88. 88
    CHIRHOSTIM (human secretin) for injection · SPL version 20251008 · published 2025-11-17 ↗

    DailyMed · U.S. National Library of Medicine · Official source · Source checked November 15, 2026

  89. 89
    Drugs@FDA: CHIRHOSTIM (secretin synthetic human), NDA 021256 · original approval April 9, 2004 ↗

    U.S. Food and Drug Administration · Official source · Source checked November 15, 2026

  90. 90
    GATTEX (teduglutide) kit · SPL version 20 · published 2025-09-18 ↗

    DailyMed · U.S. National Library of Medicine · Official source · Source checked November 15, 2026

  91. 91
    Drugs@FDA: GATTEX (teduglutide), NDA 203441 · original approval December 21, 2012 ↗

    U.S. Food and Drug Administration · Official source · Source checked November 15, 2026

  92. 92
    Drugs@FDA: COPAXONE (glatiramer acetate), NDA 020622 · original approval December 20, 1996 ↗

    U.S. Food and Drug Administration · Official source · Source checked November 16, 2026

  93. 93
    COPAXONE (glatiramer acetate injection) · SPL version 36 · published 2026-06-26 ↗

    DailyMed · U.S. National Library of Medicine · Official source · Source checked November 16, 2026

  94. 94
    DAYBUE (trofinetide) solution; DAYBUE STIX (trofinetide) for solution · SPL version 12 · published 2026-09-11 ↗

    DailyMed · U.S. National Library of Medicine · Official source · Source checked November 15, 2026

  95. 95
    Drugs@FDA: DAYBUE (trofinetide), NDA 217026 · original approval March 10, 2023 ↗

    U.S. Food and Drug Administration · Official source · Source checked November 15, 2026

  96. 96
    PRIALT (ziconotide acetate) injection, solution · SPL version 6 · published 2025-07-14 ↗

    DailyMed · U.S. National Library of Medicine · Official source · Source checked July 22, 2026

  97. 97
    Drugs@FDA application NDA021060 · original submission status AP · 2004-12-28 · dataset 2026-08-13 ↗

    Drugs@FDA via openFDA · Official source · Source checked August 14, 2026

  98. 98
    SCENESSE (afamelanotide) implant · SPL version 11 · published 2026-05-13 ↗

    DailyMed · U.S. National Library of Medicine · Official source · Source checked July 22, 2026

  99. 99
    Drugs@FDA application NDA210797 · original submission status AP · 2019-10-08 · dataset 2026-08-13 ↗

    Drugs@FDA via openFDA · Official source · Source checked August 14, 2026

  100. 100
    KORSUVA (difelikefalin) injection, solution · SPL version 9 · published 2025-09-01 ↗

    DailyMed · U.S. National Library of Medicine · Official source · Source checked November 15, 2026

  101. 101
    Drugs@FDA: KORSUVA (difelikefalin acetate), NDA 214916 · original approval August 23, 2021 ↗

    U.S. Food and Drug Administration · Official source · Source checked November 15, 2026

  102. 102
    VYLEESI (bremelanotide) injection · SPL version 1 · published 2025-11-18 ↗

    DailyMed · U.S. National Library of Medicine · Official source · Source checked July 22, 2026

  103. 103
    Drugs@FDA application NDA210557 · original submission status AP · 2019-06-21 · dataset 2026-08-13 ↗

    Drugs@FDA via openFDA · Official source · Source checked August 14, 2026

  104. 104
    CETROTIDE (cetrorelix acetate) kit · SPL version 18 · published 2025-09-29 ↗

    DailyMed · U.S. National Library of Medicine · Official source · Source checked November 15, 2026

  105. 105
    Drugs@FDA: CETROTIDE (cetrorelix acetate), NDA 021197 · original approval August 11, 2000 ↗

    U.S. Food and Drug Administration · Official source · Source checked November 15, 2026

  106. 106
    Ganirelix acetate injection, solution (Organon LLC) · SPL version 10 · published 2026-10-12 ↗

    DailyMed · U.S. National Library of Medicine · Official source · Source checked November 15, 2026

  107. 107
    Drugs@FDA: Ganirelix acetate (Organon), NDA 021057 · original approval July 29, 1999 ↗

    U.S. Food and Drug Administration · Official source · Source checked November 15, 2026

  108. 108
    FIRAZYR (icatibant acetate) injection, solution · SPL version 19 · published 2025-07-17 ↗

    DailyMed · U.S. National Library of Medicine · Official source · Source checked November 15, 2026

  109. 109
    Drugs@FDA: FIRAZYR (icatibant acetate), NDA 022150 · original approval August 25, 2011 ↗

    U.S. Food and Drug Administration · Official source · Source checked November 15, 2026

  110. 110
    EMPAVELI (pegcetacoplan) injection · SPL version 14 · published 2026-08-25 ↗

    DailyMed · U.S. National Library of Medicine · Official source · Source checked November 15, 2026

  111. 111
    Drugs@FDA: EMPAVELI (pegcetacoplan), NDA 215014 · original approval May 14, 2021 ↗

    U.S. Food and Drug Administration · Official source · Source checked November 15, 2026

  112. 112
    Drugs@FDA: SYFOVRE (pegcetacoplan), NDA 217171 · original approval February 17, 2023 ↗

    U.S. Food and Drug Administration · Official source · Source checked November 15, 2026

  113. 113
    Drugs@FDA: KYPROLIS (carfilzomib), NDA 202714 · original approval July 20, 2012 ↗

    U.S. Food and Drug Administration · Official source · Source checked November 16, 2026

  114. 114
    KYPROLIS (carfilzomib) for injection · SPL version 59 · published 2025-06-26 ↗

    DailyMed · U.S. National Library of Medicine · Official source · Source checked November 16, 2026

  115. 115
    FIRMAGON (degarelix) kit · SPL version 18 · published 2024-02-01 ↗

    DailyMed · U.S. National Library of Medicine · Official source · Source checked November 15, 2026

  116. 116
    Drugs@FDA: FIRMAGON (degarelix acetate), NDA 022201 · original approval December 24, 2008 ↗

    U.S. Food and Drug Administration · Official source · Source checked November 15, 2026

  117. 117
    Drugs@FDA: NETSPOT (gallium dotatate Ga-68), NDA 208547 · original approval June 1, 2016 ↗

    U.S. Food and Drug Administration · Official source · Source checked November 16, 2026

  118. 118
    NETSPOT (kit for the preparation of gallium Ga 68 dotatate injection) · SPL version 23 · published 2026-07-07 ↗

    DailyMed · U.S. National Library of Medicine · Official source · Source checked November 16, 2026

  119. 119
    ZOLADEX (goserelin) implant · SPL version 9 · published 2026-03-26 ↗

    DailyMed · U.S. National Library of Medicine · Official source · Source checked November 15, 2026

  120. 120
    Drugs@FDA: ZOLADEX (goserelin acetate), NDA 019726 · original approval December 29, 1989 ↗

    U.S. Food and Drug Administration · Official source · Source checked November 15, 2026

  121. 121
    ELIGARD (leuprolide acetate) injection, suspension, extended release · SPL version 19 · published 2026-05-11 ↗

    DailyMed · U.S. National Library of Medicine · Official source · Source checked November 15, 2026

  122. 122
    Drugs@FDA application NDA019010 · original submission status AP · 1985-04-09 · dataset 2026-08-13 ↗

    Drugs@FDA via openFDA · Official source · Source checked August 14, 2026

  123. 123
    Drugs@FDA application NDA019732 · original submission status AP · 1989-01-26 · dataset 2026-08-13 ↗

    Drugs@FDA via openFDA · Official source · Source checked August 14, 2026

  124. 124
    Drugs@FDA application NDA021343 · original submission status AP · 2002-01-23 · dataset 2026-08-13 ↗

    Drugs@FDA via openFDA · Official source · Source checked August 14, 2026

  125. 125
    Vobrig (leuprolide acetate): NDA 213225 approval letter, August 26, 2026 ↗

    U.S. Food and Drug Administration · Official source · Source checked November 14, 2026

  126. 126
    Drugs@FDA application NDA213225 · original submission status AP · 2026-08-26 · dataset 2026-11-13 ↗

    Drugs@FDA via openFDA · Official source · Source checked November 15, 2026

  127. 127
    LUTATHERA (lutetium Lu 177 dotatate) injection · SPL version 12 · published 2026-01-16 ↗

    DailyMed · U.S. National Library of Medicine · Official source · Source checked November 15, 2026

  128. 128
    Drugs@FDA: LUTATHERA (lutetium Lu-177 dotatate), NDA 208700 · original approval January 26, 2018 ↗

    U.S. Food and Drug Administration · Official source · Source checked November 15, 2026

  129. 129
    Drugs@FDA: BEXLUTRY (lutetium Lu-177 dotatate), NDA 218525 · original approval September 14, 2026 ↗

    U.S. Food and Drug Administration · Official source · Source checked November 15, 2026

  130. 130
    APHEXDA (motixafortide) for injection · SPL version 3 · published 2026-10-19 ↗

    DailyMed · U.S. National Library of Medicine · Official source · Source checked November 15, 2026

  131. 131
    Drugs@FDA: APHEXDA (motixafortide acetate), NDA 217159 · original approval September 8, 2023 ↗

    U.S. Food and Drug Administration · Official source · Source checked November 15, 2026

  132. 132
    TRELSTAR (triptorelin pamoate) kit · SPL version 20 · published 2026-07-10 ↗

    DailyMed · U.S. National Library of Medicine · Official source · Source checked November 15, 2026

  133. 133
    Drugs@FDA: TRELSTAR (triptorelin pamoate), NDA 020715 · original approval June 15, 2000 ↗

    U.S. Food and Drug Administration · Official source · Source checked November 15, 2026

  134. 134
    Forzinity (elamipretide): NDA 215244 accelerated approval letter, September 19, 2025 ↗

    U.S. Food and Drug Administration · Official source · Source checked September 15, 2026

  135. 135
    FORZINITY, revised September 2025: U.S. prescribing information ↗

    U.S. Food and Drug Administration · Official source · Source checked September 15, 2026

  136. 136
    ZILBRYSQ (zilucoplan) injection, solution · SPL version 13 · published 2026-02-05 ↗

    DailyMed · U.S. National Library of Medicine · Official source · Source checked November 15, 2026

  137. 137
    Drugs@FDA: ZILBRYSQ (zilucoplan sodium), NDA 216834 · original approval October 17, 2023 ↗

    U.S. Food and Drug Administration · Official source · Source checked November 15, 2026

  138. 138
    Drugs@FDA: DALVANCE (dalbavancin hydrochloride), NDA 021883 · original approval May 23, 2014 ↗

    U.S. Food and Drug Administration · Official source · Source checked November 16, 2026

  139. 139
    DALVANCE (dalbavancin) for injection · SPL version 29 · published 2025-11-17 ↗

    DailyMed · U.S. National Library of Medicine · Official source · Source checked November 16, 2026

  140. 140
    CUBICIN RF (daptomycin) injection, powder, lyophilized, for solution · SPL version 22 · published 2025-06-20 ↗

    DailyMed · U.S. National Library of Medicine · Official source · Source checked November 15, 2026

  141. 141
    Drugs@FDA: CUBICIN and CUBICIN RF (daptomycin), NDA 021572 · original approval September 12, 2003 ↗

    U.S. Food and Drug Administration · Official source · Source checked November 15, 2026

  142. 142
    MIMRYLO (rusfertide) kit · SPL version 5 · published 2026-11-11 ↗

    DailyMed · U.S. National Library of Medicine · Official source · Source checked November 15, 2026

  143. 143
    Drugs@FDA: MIMRYLO (rusfertide acetate), NDA 220605 · original approval August 28, 2026 ↗

    U.S. Food and Drug Administration · Official source · Source checked November 15, 2026